Company
Cerevance
Cerevance is focused on the development of cell-type specific treatments for neurodegenerative, psychiatric, and CNS-controlled metabolic disorders.
Also known as Cerevance, LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Boston, MA, United States
- Legal name
- Cerevance, LLC
- cerevance.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Leveraging a vast and expanding collection of over 16,000 human brain tissue samples, Cerevance is uncovering subtle molecular changes that contribute to disease progression, providing a potentially transformative tool to identify novel drug targets for CNS disorders.
Funding snapshot
- Total raised
- $20MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series C, $20M2026-05-12
Funding rounds
- Series C
- $20M2026-05-12, Company stated
Loading relationship preview